Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × Blood Specimen Collection × Clear all

Phase

Phase NA 3 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4 Colorectal Neoplasms 3 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 High Grade Neuroendocrine Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Glioblastoma 1 Cytomegalovirus Infections 1 Colonic Neoplasms 1

Interventions

aldesleukin 18 Sunitinib 18 Interferon-alpha 13 Bevacizumab 13 Interleukin-2 12 Cyclophosphamide 12 Gemcitabine 11 Everolimus 11 fludarabine phosphate 10 Sorafenib 8 Peripheral Blood Stem Cell Transplantation 8 Axitinib 8 Nivolumab 7 Ipilimumab 6 sargramostim 5 pembrolizumab 5 Filgrastim 5 Doxorubicin 5 Carboplatin 5 Capecitabine 5 cabozantinib 4 Thalidomide 4 Tacrolimus 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Bortezomib 4 temsirolimus 3 fludarabine 3 Radiotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05241561 2022-06-01

Cabo-POLARIS

Centre Hospitalier Universitaire de Besancon

Phase 2 Not yet recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡